No h: Dose oral estabelecida Estudos clnicos de segurana para uso sistmico Registro regulatrio como suplemento ou medicamento oral Alm disso, a ingesto de peptdeos ligados a metais pode gerar: Baixa biodisponibilidade Metabolizao inadequada Risco de desequilbrio metablico O local de ao do GHK-Cu a pele, e sua eficcia depende da aplicao tpica, onde ele atua diretamente no microambiente cutneo
VEGF-R2 axis / local angiogenesis BPC-157 upregulates VEGF-R2 (KDR) receptor expression on vascular endothelium at the lesion site, triggering early neoangiogenesis required for tendon and ligament repair (Sikiric 2018, successive reviews)
Among the SLCs, the plasma membrane transporters OCTN2 (Organic cation transport novel 2 or SLC22A5), CT2 (Carnitine transporter 2 or SLC22A16), MCT9 (Monocarboxylate transporter 9 or SLC16A9) and ATB 0, + [Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) or SLC6A14] together with the mitochondrial membrane transporter CAC (Mitochondrial carnitine/acylcarnitine carrier or SLC25A20) are the most acknowledged to mediate the flux of carnitine
These included TCA cycle intermediates such as citrate, cis -aconitate, -ketoglutarate, and various amino acids including glutamate, proline, aspartate, asparagine, and alanine as well as glutathione, pyroglutamate, and ornithine
The advantage here is small injection volumes, which matters for subcutaneous comfort